Wedbush Securities has upgraded Nu Skin Enterprises (NYSE:
NUS) from Neutral to Outperform and has raised the price target from $40 to $48.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.